Skip to main content
OpenTrials
Completed

NCT Number: NCT07353203

Safety and Efficacy of Hip Assist Powered Exoskeleton for Gait Training in Patients With Late Subacute and Chronic Stroke

The aim of this study is to evaluate the safety of gait training using a hip-assist powered exoskeleton. This will be assessed by collecting all device-related adverse events occurring during the entire intervention period, which consists of a total of 10 sessions within 5 weeks across two different gait rehabilitation protocols.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Samsung Medical Center

Seoul, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 19 to 85 years.
  • Patients with hemiplegia resulting from ischemic or hemorrhagic stroke.
  • Patients in the late subacute or chronic phase, with stroke onset of 3 months or more (in cases of recurrent stroke, based on the most recent event). Functional Ambulation Category (FAC) score of 3 or higher.
  • Patients capable of safely wearing the hip-assist powered exoskeleton and using it with minimal assistance.
  • Height: 140 cm - 190 cm
  • Weight: 80 kg or less
  • Patients who were capable of independent walking and had no disability in daily self-care activities prior to stroke onset (based on the last stroke for recurrent patients). (mRS ≤2)
  • Patients who have received approval for study participation from the attending medical staff.

Exclusion criteria

  • Severe cognitive impairment (Mini-Mental State Examination [MMSE] < 10) or severe speech impairment/aphasia.
  • History of major orthopedic surgery, such as hip, knee, or ankle arthroplasty, within the last 3 months.
  • Fractures, open wounds, or unhealed ulcers in the lower extremities.
  • Patients for whom gait training with the powered orthopedic device is difficult due to severe medical conditions, such as cardiovascular or pulmonary diseases.
  • History of osteoporotic fractures.
  • Patients with other neurological diseases affecting gait (e.g., Parkinson's disease, multiple sclerosis, etc.).
  • Any other cases where the investigator deems participation in the study to be inappropriate.

Treatment and study plan

gait assistance mode group

Device

A total of 10 sessions of gait training were performed using the hip-assist powered exoskeleton for 5 weeks (30 minutes per session)

Resistance mode

Device

A total of 10 sessions of gait training were performed using the hip-assist powered exoskeleton for 5 weeks (30 minutes per session)

Primary outcomes

  1. 10 Meter Walk Test

    Time frame: Baseline, after 5 intervention sessions(week 3) , and after 10 intervention sessions(Week 5)

    (lower limb motor score in 10 Meter Walk test at post-intervention) - (lower limb motor score in 10 Meter Walk Test at baseline) Higher scores mean a better outcome

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Official study title

Safety and Efficacy of Hip Assist Powered Exoskeleton for Gait Training in Patients With Late Subacute and Chronic Stroke, Multi-center, Randomized Controlled Pilot Study

Acronym: brain disorder

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 20, 2026
Registry last updated
Apr 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.